Results 211 to 220 of about 10,251 (261)

Torasemide Decreases Kynurenic Acid Production in Rat Kidney In Vitro

Journal of the American Society of Nephrology, 2023
Background: AKI due to sepsis is the result of a dysregulated host immune response to infection, with the production of inflammatory mediators and cytokines. Jafron HA380 cartridge has been specifically designed for cytokine storm in sepsis.
I. Zakrocka, Wojciech T. Zaluska
semanticscholar   +1 more source

Ivabradine/Spironolactone/Torasemide

Reactions Weekly
openaire   +2 more sources

Crystalline salts of a diuretic drug torasemide with improved solubility and dissolution properties

CrysteEngComm, 2022
Two novel pharmaceutical crystalline salts of a diuretic drug torasemide with improved solubility and dissolution profiles are disclosed in this manuscript.
Monika Garg, Mayank Singh, S. Koli, B. Sreedhar, S. Ramakrishna, J. Nanubolu   +5 more
semanticscholar   +1 more source

Azosemide/indapamide/torasemide

Reactions Weekly, 2022
openaire   +2 more sources

Icodextrin/Torasemide

Reactions Weekly
openaire   +2 more sources

EFFECT OF TORASEMIDE AND INDAPAMIDE ON MAGNESIUM, POTASSIUM, CAL- CIUM AND SODIUM EXCRETION IN POST-MENOPAUSAL WOMEN WITH HYPERTEN- SION AND CHRONIC HEART FAILURE DEPENDING ON MAGNESIUM DEFICIENCY

Tavricheskiy Mediko-Biologicheskiy Vestnik, 2022
The aim of study was to assess torasemide and indapamide effects on magnesium (Mg), potassium (K), calcium (Ca), and sodium (Na) excretion in postmenopausal women with hypertension and heart failure with preserved ejection fraction (HFpEF) depending on ...
D. Mailyan, V. Kolomiyets, E. Maylyan, N. Reznichenko   +3 more
semanticscholar   +1 more source

Torasemide in hypertension and heart failure: re-inventing loop diuretic therapy?

Current pharmaceutical design, 2021
In heart failure (HF) patients, current European Society of Cardiology (ESC) guidelines recommends the use of three loop diuretics (furosemide, torasemide, bumetanide) in order to reduce HF hospitalizations but also to improve symptoms and exercise ...
A. Manolis, M. Kallistratos, M. Doumas
semanticscholar   +1 more source

Tolvaptan/Torasemide

Reactions Weekly
openaire   +2 more sources

Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.

Journal of Evaluation In Clinical Practice, 2020
AIM Diuretics are a cornerstone in treatment of heart failure (HF). Torasemide is a loop diuretic with a potential advantage over other diuretics. We aim to meta-analyse and compare the effect of torasemide with furosemide in HF patients.
Nourin Ali Sherif, M. E. Morra, Le Thai Van Thanh, Ghadeer Gamal Elsayed, A. Elkady, Abdelrahman Elshafay, Nguyen Dang Kien, Ahmed Al-Habbaa, Minh H. N. Le, M. Y, Thai Le Ba Nghia, A. Mohammed, Peter Samuel Eid, Tarek Turk, K. Hirayama, N. Huy   +15 more
semanticscholar   +1 more source

Torasemide Prolonged Release

Drugs, 2009
Torasemide prolonged release (PR), a high-ceiling diuretic, inhibits renal tubular reabsorption of sodium and chloride in the thick ascending limb of the loop of Henle. Relative to the immediate-release (IR) formulation, the PR formulation of torasemide was associated with similar systemic exposure, but significantly slower rates of absorption and ...
openaire   +2 more sources